查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040648

美國藥物檢測市場規模、佔有率和趨勢分析報告：按產品、檢體、藥物、最終用途和細分市場預測（2026-2033 年）

U.S. Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples), By Drug (Alcohol, Opioids), By End Use (Drug Testing Laboratories, Workplaces, Hospitals), And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國藥物檢測市場概況

據估計，美國藥物檢測市場在 2025 年的價值為 26.2 億美元，預計到 2033 年將達到 41.3 億美元，2026 年至 2033 年的複合年成長率為 5.89%。

推動這一市場成長的因素包括：藥物濫用日益嚴重、更嚴格的法規強制進行藥物和酒精檢測，以及美國政府加強遏制藥物濫用。

根據美國藥物濫用和精神衛生管理局（SAMHSA）發布的2024年全國藥物使用與健康調查，約有7360萬12歲及以上的美國人（佔總人口的25.5%）報告在過去一年中使用過非法藥物。大麻仍是最常使用的非法藥物，約有6,420萬使用者，其次是致幻劑、處方鴉片和古柯鹼等物質。

此外，各行各業對職場安全和合規性的日益重視也推動了美國藥物檢測市場的擴張。雇主法律責任的許多問題促使人們採用藥物檢測方案，包括入職前檢測、隨機檢測和離職後檢測，從而支持了市場需求。職場和醫療保健機構藥物檢測的普及也進一步促進了市場成長。此外，美國政府正積極進行全國性宣傳活動，意識提升。諸如「全國藥物和酒精知識週」以及美國緝毒局（DEA）開展的宣傳活動等項目，為學校、社區和職場提供預防藥物濫用的資源。

美國藥物濫用問題的日益普遍顯著增加了對藥物檢測解決方案的需求。此外，持續不斷的鴉片類藥物危機凸顯了醫療保健、職場和執法機關進行監測和檢測計畫的必要性。根據美國疾病管制與預防中心 (CDC) 預測，2023 年美國將有超過 10.7 萬人死於藥物過量，凸顯了藥物濫用對公共衛生的嚴重影響。藥物濫用和過量用藥的增加促使政府、雇主和醫療保健機構實施常規藥物篩檢和監測項目，從而推動了美國藥物檢測市場的成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：美國藥物檢測市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 美國藥物檢測市場分析工具
  • 法律規範
  • 救贖方案

第4章：美國藥物檢測市場：按產品分類的估算與趨勢分析

  • 美國藥物檢測市場：基於產品的波動分析
  • 美國藥物檢測市場：依產品分類及展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 消耗品
  • 裝置
  • 快速檢測設備
  • 服務

第5章：美國藥物檢測市場：依樣本類型分類的估算與趨勢分析

  • 美國藥物檢測市場：按樣本類型分類的波動分析
  • 美國藥物檢測市場：依樣本類型分類，展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 尿液檢體
  • 口腔液樣本
  • 頭髮樣本
  • 其他檢體

第6章：美國藥物檢測市場：依藥物類型分類的估算與趨勢分析

  • 美國藥物檢測市場：按藥物類型分類的波動分析
  • 美國藥物檢測市場：依藥物類型分類，展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 酒精
  • 大麻/醫用大麻
  • 古柯鹼
  • 鴉片類藥物
  • 安非他命和甲基安非他命
  • LSD
  • 其他

第7章：美國藥物檢測市場：依最終用途分類的估算與趨勢分析

  • 美國藥物檢測市場：按最終用途分類的波動分析
  • 美國藥物檢測市場：依最終用途分類，展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 藥物檢測實驗室
  • 職場
  • 醫院
  • 其他

第8章 競爭情勢

  • 參與企業的分類
  • 主要市場參與企業的最新趨勢及影響分析
  • 企業市場占有率分析，2025 年
  • 主要公司簡介
    • Quest Diagnostics Incorporated
    • Abbott
    • Laboratory Corporation of America Holdings（Labcorp）
    • Thermo Fisher Scientific, Inc.
    • OraSure Technologies, Inc.
    • Psychemedics Corporation
    • Omega Laboratories, Inc
    • Premier Biotech, Inc
    • Alfa Scientific Designs, Inc
Product Code: GVR-4-68040-886-0

U.S. Drug Testing Market Summary

The U.S. drug testing market size was estimated at USD 2.62 billion in 2025, projected to reach USD 4.13 billion by 2033, expanding at a CAGR of 5.89% from 2026 to 2033. The growth of the market is driven by rising prevalence of substance abuse, stringent regulations requiring drug & alcohol testing, and growing government efforts to curb substance abuse in the U.S.

According to the Substance Abuse and Mental Health Services Administration (SAMHSA) 2024 national survey on drug use and health, about 73.6 million Americans aged twelve or older (25.5%) reported using illicit drugs in the past year. Cannabis remains the commonly used illicit drug, with around 64.2 million users, followed by substances such as hallucinogens, prescription opioids, and cocaine.

Furthermore, growing emphasis on workplace safety and compliance across industries is also supporting the expansion of the U.S. drug testing market. Many employer liability issues are driving the adoption of pre-employment, random, and post-incident drug testing programs, supporting market demand. The expansion of drug testing across workplaces and healthcare settings further contributes to growth. Moreover, the U.S. government actively promotes national campaigns to raise awareness about the dangers of substance abuse. Programs such as "National Drug & Alcohol Facts Week" and the DEA's educational outreach provide schools, communities, and workplaces with resources to prevent drug misuse.

The increasing prevalence of substance abuse in the U.S. has significantly raised the demand for drug testing solutions. The ongoing opioid crisis has also increased the need for monitoring and testing programs across healthcare, workplace, and law enforcement sectors. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded over 107,000 drug overdose deaths in 2023, highlighting the serious public health impact of drug misuse. These rising cases of substance misuse and overdose are encouraging governments, employers, and healthcare providers to adopt regular drug screening and monitoring programs, which is supporting the growth of the U.S. drug testing market.

U.S. Drug Testing Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the U.S. drug testing market report on the basis of test, application, and end use.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
    • Consumables
    • Instruments
    • Rapid Testing Devices
    • Services
  • Sample Type Outlook (Revenue, USD Million, 2021 - 2033)
    • Urine Samples
    • Oral Fluid Samples
    • Hair Samples
    • Other Samples
  • Drug Type Outlook (Revenue, USD Million, 2021 - 2033)
    • Alcohol
    • Cannabis/Marijuana
    • Cocaine
    • Opioids
    • Amphetamine & Methamphetamine
    • LSD
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
    • Drug Testing Laboratories
    • Workplaces
    • Hospitals
    • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Sample type
    • 1.2.3. Drug type
    • 1.2.4. End use
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Objectives
    • 1.3.1. Objective-1
    • 1.3.2. Objective-2
    • 1.3.3. Objective-3
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased database
    • 1.5.2. GVR's internal database
    • 1.5.3. Secondary sources
    • 1.5.4. Primary research
  • 1.6. Information or Data Analysis
    • 1.6.1. Data analysis models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity flow analysis
      • 1.8.1.1. Approach 1: Commodity flow approach
      • 1.8.1.2. Approach 2: Country-wise market estimation using bottom-up approach
  • 1.9. List of Secondary Sources
  • 1.10. List of Primary Sources
  • 1.11. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Product Snapshot
  • 2.3. Sample Snapshot
  • 2.4. Drug and End-use Snapshot
  • 2.5. Competitive Insights

Chapter 3. U.S. Drug Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook (Drug Testing Market)
    • 3.1.2. Related/ancillary market outlook (Drug Screening Market)
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of substance abuse
      • 3.2.1.2. Stringent regulations requiring drug and alcohol testing
      • 3.2.1.3. Growing government efforts to curb substance abuse
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulatory framework for drug testing products
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Expansion of testing in new industries
      • 3.2.3.2. Policies like the Affordable Care Act (ACA)
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Economic Downturns
      • 3.2.4.2. Reduction in corporate spending
  • 3.3. U.S. Drug Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
  • 3.4. Regulatory Framework
  • 3.5. Reimbursement Scenario

Chapter 4. U.S. Drug Testing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Drug Testing Market: Product Movement Analysis
  • 4.3. U.S. Drug Testing Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Consumables
    • 4.5.1. Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Instruments
    • 4.6.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Rapid Testing Devices
    • 4.7.1. Rapid Testing Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Rapid Testing Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Services
    • 4.8.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.8.2. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Drug Testing Market: Sample Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Drug Testing Market: Sample Type Movement Analysis
  • 5.3. U.S. Drug Testing Market by Sample Type Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Urine Samples
    • 5.5.1. Urine Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Urine Samples Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
  • 5.6. Oral Fluid Samples
    • 5.6.1. Oral Fluid Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. Oral Fluid Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Hair Samples
    • 5.7.1. Hair Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.2. Hair Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Other Sample
    • 5.8.1. Other Sample Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.8.2. Other Sample Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Drug Testing Market: Drug Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Drug Testing Market: Drug Type Movement Analysis
  • 6.3. U.S. Drug Testing Market by Drug Type Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Alcohol
    • 6.5.1. Alcohol Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Alcohol Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Cannabis/Marijuana
    • 6.6.1. Cannabis/Marijuana Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Cannabis/Marijuana Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Cocaine
    • 6.7.1. Cocaine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Cocaine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Opioids
    • 6.8.1. Opioids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. Opioids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Amphetamine & Methamphetamine
    • 6.9.1. Amphetamine & Methamphetamine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.9.2. Amphetamine & Methamphetamine Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.10. LSD
    • 6.10.1. LSD Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.10.2. LSD Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.11. Others
    • 6.11.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.11.2. Others Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 7. U.S. Drug Testing Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Drug Testing Market: End Use Movement Analysis
  • 7.3. U.S. Drug Testing Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. Drug Testing Laboratories
    • 7.5.1. Drug Testing Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Drug Testing Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
  • 7.6. Workplaces
    • 7.6.1. Workplaces Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Workplaces Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
  • 7.7. Hospitals
    • 7.7.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
  • 7.8. Others
    • 7.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. Others Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Recent Developments & Impact Analysis by Key Market Participants
  • 8.3. Company Market Share Analysis, 2025
  • 8.4. Key Company Profiles
    • 8.4.1. Quest Diagnostics Incorporated
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Abbott
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Laboratory Corporation of America Holdings (Labcorp)
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Thermo Fisher Scientific, Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. OraSure Technologies, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Psychemedics Corporation
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Omega Laboratories, Inc
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Premier Biotech, Inc
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Alfa Scientific Designs, Inc
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 4 U.S. drug testing market, by sample, 2021 - 2033 (USD Million)
  • Table 5 The detection span for drugs using urine samples
  • Table 6 The detection span for drugs using oral fluid samples
  • Table 7 The detection span for drugs using hair samples
  • Table 8 U.S. drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 9 U.S. drug testing market, by end use, 2021 - 2033 (USD Million)
  • Table 10 Key players involved in mergers and acquisitions
  • Table 11 Key players involved in partnerships and collaboration
  • Table 12 Key players involved in new product launch
  • Table 13 Key players involved in other strategies

List of Figures

  • Fig. 1 U.S. drug testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. drug testing market snapshot
  • Fig. 10 Test snapshot
  • Fig. 11 Application and end-use snapshot
  • Fig. 12 Competitive landscape snapshot
  • Fig. 13 Parent market outlook
  • Fig. 14 Related/ancillary market outlook
  • Fig. 15 Market dynamics
  • Fig. 16 Market driver analysis (current & future impact)
  • Fig. 17 Market restraint analysis (current & future impact)
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 20 Industry analysis - Porter's
  • Fig. 21 U.S. drug testing market Product outlook key takeaways
  • Fig. 22 U.S. drug testing market, Product movement analysis
  • Fig. 23 Consumables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Instruments market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Rapid testing devices market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. drug testing market: Sample type outlook and key takeaways
  • Fig. 28 U.S. drug testing market: Sample type movement analysis
  • Fig. 29 Urine samples market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Oral fluid samples market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Hair samples market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Other sample market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. drug testing market: Drug type outlook and key takeaways
  • Fig. 34 U.S. drug testing market: Drug type movement analysis
  • Fig. 35 Alcohol market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Cannabis/Marijuana market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Cocaine market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Opioids market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Amphetamine & methamphetamine market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 40 LSD market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 LSD drug use in the past year among people aged 12 or older; by age group, 2021, in U.S.
  • Fig. 42 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 U.S. drug testing market: End use outlook and key takeaways
  • Fig. 44 U.S. drug testing market: End use movement analysis
  • Fig. 45 Drug testing laboratories market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Workplaces market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Alcohol use disorder diagnose among age groups
  • Fig. 50 Key company categorization
  • Fig. 51 U.S. drug testing market share analysis, 2025
  • Fig. 52 Strategy mapping